138 related articles for article (PubMed ID: 33468750)
1. [A Case of Long-Term Survival of Anaplastic Transformation of Thyroid Cancer in Lymph Node Metastasis Due to Radiation Therapy and Lenvatinib].
Masuda G; Hori T; Tani N; Sakimura C; Teramura K; Tendo M; Nakata B; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2021 Jan; 48(1):148-150. PubMed ID: 33468750
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of Lenvatinib for Thyroid Cancer with Lung Metastases - Report of a Case].
Nagashima S; Matsuo S; Takahashi M; Umemoto Y; Hirano T; Enomoto K; Sakurai K; Amano S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2121-2123. PubMed ID: 28133242
[TBL] [Abstract][Full Text] [Related]
3. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
Mahajan P; Dawrant J; Kheradpour A; Quintanilla NM; Lopez ME; Orth RC; Athanassaki I; Venkatramani R
Thyroid; 2018 Nov; 28(11):1450-1454. PubMed ID: 30226445
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic Thyroid Carcinoma Treated with Lenvatinib.
Ohkubo JI; Takahashi A; Ikezaki S; Takenaga F; Ohkubo Y; Suzuki H
Kurume Med J; 2018 Feb; 64(1.2):29-33. PubMed ID: 29057760
[TBL] [Abstract][Full Text] [Related]
5. Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an
Ito Y; Ishikawa H; Kihara M; Hirokawa M; Kiyota N; Kasahara T; Miyauchi A
Thyroid; 2019 Oct; 29(10):1511-1517. PubMed ID: 31317827
[No Abstract] [Full Text] [Related]
6. Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma.
Gay S; Monti E; Trambaiolo Antonelli C; Mora M; Spina B; Ansaldo G; Teliti M; Comina M; Conte L; Minuto M; Varaldo E; Zupo S; Massa B; Morbelli S; Giusti M
Future Oncol; 2019 Aug; 15(24s):13-19. PubMed ID: 31385546
[TBL] [Abstract][Full Text] [Related]
7. Case Report: 84-Month Disease-Free Survival after Surgery for Anaplastic Thyroid Carcinoma.
Kanazawa S; Kammori M
J Nippon Med Sch; 2019; 86(1):38-42. PubMed ID: 30918155
[TBL] [Abstract][Full Text] [Related]
8. Long-term disease control and high clinical benefit in a patient with advanced thyroid cancer treated with lenvatinib.
Muratori L; Sperone P; Scagliotti GV
Future Oncol; 2019 Aug; 15(24s):3-6. PubMed ID: 31385526
[TBL] [Abstract][Full Text] [Related]
9. Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review.
Sheu NW; Jiang HJ; Wu CW; Chiang FY; Chiou HC; Hsiao PJ
World J Surg Oncol; 2019 May; 17(1):84. PubMed ID: 31103041
[TBL] [Abstract][Full Text] [Related]
10. Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis.
Kim SY; Kim SM; Kim JW; Lee IJ; Jeon TJ; Chang H; Kim BW; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2020; 11():599. PubMed ID: 32982983
[No Abstract] [Full Text] [Related]
11. Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
Iñiguez-Ariza NM; Ryder MM; Hilger CR; Bible KC
Thyroid; 2017 Jul; 27(7):923-927. PubMed ID: 28471306
[TBL] [Abstract][Full Text] [Related]
12. [A case of anaplastic transformation of thyroid carcinoma in the cervical lymph node metastasis].
Ishibashi T; Kasai N; Sakamoto A
Gan No Rinsho; 1985 Mar; 31(3):318-22. PubMed ID: 3999394
[TBL] [Abstract][Full Text] [Related]
13. [ANAPLASTIC TRANSFORMATION OF METASTATIC PAPILLARY THYROID CARCINOMA IN A CERVICAL LYMPH NODE - A TIMELINE].
Horev Y; Vaknine H; Cinamon U
Harefuah; 2020 Nov; 159(11):809-814. PubMed ID: 33210851
[TBL] [Abstract][Full Text] [Related]
14. Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report.
Yamazaki H; Masudo K; Kanada S; Inayama Y; Hayashi H; Fujii Y; Rino Y
Surg Case Rep; 2023 Mar; 9(1):38. PubMed ID: 36920674
[TBL] [Abstract][Full Text] [Related]
15. Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study.
Lee EK; Kim SM; Kim BH; Kim MJ; Lim DJ; Kim MH; Shin DY; Kang HC; Ahn BC; Kim SW; Ahn HY; Park YJ
Thyroid; 2019 Dec; 29(12):1811-1819. PubMed ID: 31482759
[No Abstract] [Full Text] [Related]
16. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
17. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report.
Tori M; Shimo T
BMC Cancer; 2018 Jun; 18(1):698. PubMed ID: 29954369
[TBL] [Abstract][Full Text] [Related]
19. Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe.
Barbaro D; Lapi P; Viacava P; Torregrossa L
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370973
[TBL] [Abstract][Full Text] [Related]
20. Long-term management of recurrent papillary thyroid carcinoma treated with lenvatinib for over 5 years: a case report.
Imai T; Kobayashi H; Senaha T; Imaizumi T; Murata Y
Surg Case Rep; 2022 Jan; 8(1):21. PubMed ID: 35084585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]